Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Haugaard

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
European Journal of Clinical Investigation|August 13, 2004
Low-dose growth hormone and human immunodeficiency virus-associated lipodystrophy syndrome: a pilot studyO Andersen, S B Haugaard, A Flyvbjerg, et al.
HIV Medicine|December 17, 2009
Long-term high-physiological-dose growth hormone reduces intra-abdominal fat in HIV-infected patients with a neutral effect on glucose metabolismB R Hansen, S B Haugaard, F K Jensen, et al.
HIV Medicine|February 24, 2006
Glucose-stimulated prehepatic insulin secretion is associated with circulating alanine, triglyceride, glucagon, lactate and TNF-alpha in patients with HIV-lipodystrophyS B Haugaard, O Andersen, S B Pedersen, et al.
Diabetes, Obesity & Metabolism|July 24, 2010
Opposite effects of pioglitazone and rosiglitazone on mitochondrial respiration in skeletal muscle of patients with type 2 diabetesR Rabøl, R Boushel, T Almdal, et al.
HIV Medicine|April 6, 2005
Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapyO Andersen, S B Haugaard, J J Holst, et al.
The Journal of Clinical Endocrinology and Metabolism|January 12, 2010
Regional anatomic differences in skeletal muscle mitochondrial respiration in type 2 diabetes and obesityR Rabøl, S Larsen, P M V Højberg, et al.
Nutrition & Diabetes|November 17, 2012
Effect of trans fatty acid intake on abdominal and liver fat deposition and blood lipids: a randomized trial in overweight postmenopausal womenN T Bendsen, E Chabanova, H S Thomsen, et al.
Atherosclerosis|March 1, 2011
Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular eventsT Sehestedt, S Lyngbæk, J Eugen-Olsen, et al.
Diabetologia|April 25, 2013
The pro-inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is associated with incident type 2 diabetes among overweight but not obese individuals with impaired glucose regulation: effect modification by smoking and body weight statusA Heraclides, T M Jensen, S S Rasmussen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 5, 2011
The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and menS B Haugaard, O Andersen, T W Hansen, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
European Journal of Clinical Investigation|August 13, 2004
Low-dose growth hormone and human immunodeficiency virus-associated lipodystrophy syndrome: a pilot studyO Andersen, S B Haugaard, A Flyvbjerg, et al.
HIV Medicine|December 17, 2009
Long-term high-physiological-dose growth hormone reduces intra-abdominal fat in HIV-infected patients with a neutral effect on glucose metabolismB R Hansen, S B Haugaard, F K Jensen, et al.
HIV Medicine|February 24, 2006
Glucose-stimulated prehepatic insulin secretion is associated with circulating alanine, triglyceride, glucagon, lactate and TNF-alpha in patients with HIV-lipodystrophyS B Haugaard, O Andersen, S B Pedersen, et al.
Diabetes, Obesity & Metabolism|July 24, 2010
Opposite effects of pioglitazone and rosiglitazone on mitochondrial respiration in skeletal muscle of patients with type 2 diabetesR Rabøl, R Boushel, T Almdal, et al.
HIV Medicine|April 6, 2005
Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapyO Andersen, S B Haugaard, J J Holst, et al.
The Journal of Clinical Endocrinology and Metabolism|January 12, 2010
Regional anatomic differences in skeletal muscle mitochondrial respiration in type 2 diabetes and obesityR Rabøl, S Larsen, P M V Højberg, et al.
Nutrition & Diabetes|November 17, 2012
Effect of trans fatty acid intake on abdominal and liver fat deposition and blood lipids: a randomized trial in overweight postmenopausal womenN T Bendsen, E Chabanova, H S Thomsen, et al.
Atherosclerosis|March 1, 2011
Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular eventsT Sehestedt, S Lyngbæk, J Eugen-Olsen, et al.
Diabetologia|April 25, 2013
The pro-inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is associated with incident type 2 diabetes among overweight but not obese individuals with impaired glucose regulation: effect modification by smoking and body weight statusA Heraclides, T M Jensen, S S Rasmussen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 5, 2011
The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and menS B Haugaard, O Andersen, T W Hansen, et al.
Pageof 3